News

Our Healthcare News

Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year

DANVERS, Massachusetts—  Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies, today reported first quarter fiscal 2018 revenue of $132.5 million, an…  

Jul 27 2017

Grupo Biotoscana Raises $417 Million in Oversubscribed Brazil IPO

LONDON, United Kingdom—EW Healthcare Partners (“EWHP”), a global healthcare growth equity investor, announced that Grupo Biotoscana (“Biotoscana”), a Pan-Latin American specialty pharmaceutical company focused on…  

Jul 21 2017

Venus Concept Closes $38 Million Equity Financing to Support Continued Growth Opportunities

TORONTO, Canada—Venus Concept Ltd., a privately-held and innovative global aesthetic technology leader, today announced the closing of a $38 million equity investment. The equity investment…  

Jul 13 2017

EUSA Pharma Receives Positive CHMP Opinion for Tivozanib for First-Line Treatment

HEMEL HEMPSTEAD, England – – EUSA Pharma (EUSA), a specialty pharmaceutical company with a focus on oncology and oncology supportive care, today announced that the…  

Jun 23 2017

Endologix Provides an Update on the Nellix Endovascular Aneurysm Sealing System US Regulatory Status

IRVINE, California – Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that the Company met with the…  

May 17 2017

European Commission Approves the Only Immunotherapy for High-Risk Neuroblastoma

HEMEL HEMPSTEAD, England – EUSA Pharma today announced that the European Commission (EC) has approved the antibody ch14.18/CHO, dinutuximab beta, for the treatment of high-risk…  

May 09 2017

EUSA Pharma and Apeiron Biologics Receive Positive CHMP Opinion for Dinutuximab Beta

HEMEL HEMPSTEAD, England and VIENNA, Austria – – EUSA Pharma (EUSA), a specialty pharmaceutical company with a focus on oncology and oncology supportive care, and…  

Mar 27 2017

Xenex Secures $38 Million in Funding Led by Essex Woodlands & Piper Jaffray Merchant Banking

SAN ANTONIO, Texas—Xenex Disinfection Services, the manufacturer of LightStrike Germ-Zapping Robots™, today announced the investment of $38 million in a funding round led by Essex…  

Feb 24 2017

Endologix Completes Patient Enrollment in the Ovation LUCY Study

IRVINE, California (GLOBE NEWSWIRE)—Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has completed patient enrollment in the…  

Feb 14 2017



View Legacy Fund news >